ActivMed Practices and Research

Executive Summary

ActivMed Practices & Research, LLC is a multi-specialty clinical research site organization (CRO/SMO) founded in 1994 and headquartered in Beverly, Massachusetts. The company operates four clinical sites across northern Massachusetts and southern New Hampshire, conducting Phase I-IV trials for pharmaceutical, biotechnology, medical device, and nutraceutical sponsors. With a mission emphasizing quality care, quality data, and quality recruitment, ActivMed covers a broad range of therapeutic areas, positioning itself as a reliable partner for sponsors seeking efficient and high-quality clinical trial execution. The company's long-standing presence since 1994 and its focus on regional clinical research have established it as a key player in the New England clinical research ecosystem, though it remains a private entity with limited public financial disclosures. ActivMed's operational strength lies in its proven ability to recruit and retain diverse patient populations across its four sites, contributing to its reputation for delivering data integrity and regulatory compliance. The company continues to seek growth through new trial awards and potential site expansions, capitalizing on the increasing demand for decentralized and hybrid trial models. While no specific financial metrics are publicly available, ActivMed's sustained operations over three decades suggest stable client relationships and a robust pipeline of studies. Its conviction score reflects moderate confidence given the lack of recent catalysts or major announcements, but its established track record and regional foothold provide a foundation for steady organic growth.

Upcoming Catalysts (preview)

• Q3 2026Award of New Phase II/III Trials in Neurology60% success
• Q4 2026Expansion to a Fifth Clinical Site in Southern New Hampshire40% success
• Q2 2026Partnership with a Top 20 Pharma for Vaccine Trial Portfolio50% success